Skip to main content
. 2018 Jun 18;15:49. doi: 10.1186/s12984-018-0398-3

Table 2.

Characteristics of the subjects

Healthy Controls Patients with Parkinson’s Disease p-value Non-fallers Fallers p-value
# of subjects 39 (19) 101 (24) 64 25
Age (years) 77.8 ± 3.9 (76.6 ± 1.4) 64.5 ± 9.3 (75.1 ± 2.2) <  0.001 0.147 63.7 ± 9.8 67.1 ± 9.2 0.14
Gender (% women) 64 (63) 24 (25) <  0.001 (0.011) 20 0 0.44
Height (cm) 163.1 ± 6.5 (163.0 ± 6.3) 169.4 ± 8.8 (167.1 ± 9.9) <  0.001 (0.107) 170.7 ± 8.9 168.2 ± 8.8 0.24
Weight (kg) 71.3 ± 13.2 (68.5 ± 12.6) 76.5 ± 11.9 (77.0 ± 10.8) 0.11 (0.030) 75.9 ± 10.5 80.2 ± 14.2 0.12
UPDRS Part III (motor) 0 39.8 ± 12.9 (42.6 ± 11.9) 39.8 ± 13.6 41.3 ± 10.6 0.97
Disease duration (years) 0 5.4 ± 3.3 (5.2 ± 2.3) 5.1 ± 2.8 6.7 ± 4.4 0.02
Levodopa equivalent dose 0 520.3 ± 314.4 (499.0 ± 300.8) 480.0 ± 271.6 582.3 ± 348.0 0.18

Note: Characteristics of the age matched subset of the PD cohort are presented in parenthesis